Physician profile
Deborah Martin
NPI 1518166636
$2,515.24
in general payments reported to CMS, 2019-2025
16 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $399 · 2022: $818 · 2023: $526 · 2024: $569 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $760.20 | 2021-2025 | |
| Gilead Sciences, INC. | $510.10 | 2022-2024 | Epclusa |
| Janssen Biotech, INC. | $371.12 | 2021-2024 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $208.41 | 2021-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $123.31 | 2022-2025 | Entyvio, Gattex |
| Madrigal Pharmaceuticals | $122.93 | 2024 | Rezdiffra |
| Intercept Pharmaceuticals, INC. | $122.70 | 2024 | |
| Ardelyx, INC. | $62.82 | 2024-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $46.92 | 2024-2025 | Voquezna |
| Celgene Corporation | $41.38 | 2023 | Zeposia |
| Lilly USA, LLC | $37.46 | 2024-2025 | Omvoh |
| Aimmune Therapeutics, INC. | $32.66 | 2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $22.65 | 2023 | |
| Genzyme Corporation | $21.06 | 2022 | |
| Organon LLC | $18.46 | 2023 | Renflexis, Hadlima |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $13.06 | 2023 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.